Toll样受体5(TLR5)重组蛋白
产品名称: Toll样受体5(TLR5)重组蛋白
英文名称: Recombinant Toll Like Receptor 5 (TLR5)
产品编号: YB990Hu031
产品价格: 0
产品产地: 中国/美国
品牌商标: 钰博生物/Ybscience
更新时间: 2023-08-17T10:29:50
使用范围: null
- 联系人 : 陈环环
- 地址 : 上海市沪闵路6088号龙之梦大厦8楼806室
- 邮编 : 200612
- 所在区域 : 上海
- 电话 : 183****2235 点击查看
- 传真 : 点击查看
- 邮箱 : shybio@126.com
- 二维码 : 点击查看
Toll样受体5(TLR5)重组蛋白
YB990Hu031
Recombinant Toll Like Receptor 5 (TLR5)
Organism Species: Homo sapiens (Human)
Instruction manual
FOR IN VITRO USE AND RESEARCH USE ONLY
NOT FOR USE IN CLINICAL DIAGNOSTIC PROCEDURES
10th Edition (Revised in Jan, 2014)
Toll样受体5(TLR5)重组蛋白[ PROPERTIES ]
Residues: Asn46~Ala205
Tags: Two N-terminal Tags, His-tag and S-tag
Accession: O60602
Host: E. coli
Subcellular Location: Membrane; Single-pass
type I membrane protein.
Purity: >95%
Endotoxin Level: <1.0EU per 1μg
Toll样受体5(TLR5)重组蛋白(determined by the LAL method).
Formulation: Supplied as lyophilized form in 10mM
PBS, pH7.4, containing 1mM DTT, 5% trehalose,
0.01% sarcosyl and preservative.
Predicted isoelectric point: 6.4
Predicted Molecular Mass: 23.8kDa
Applications: SDS-PAGE; WB; ELISA; IP.
(May be suitable for use in other assays to be determined by the end user.)
[ USAGE ]
Reconstitute in sterile ddH2O.
[ STORAGE AND STABILITY ]
Storage: Avoid repeated freeze/thaw cycles.
Store at 2-8oC for one month.
Aliquot and store at -80oC for 12 months.
Stability Test: The thermal stability is described by the loss rate of the target
protein. The loss rate was determined by accelerated thermal degradation test,
that is, incubate the protein at 37oC for 48h, and no obvious degradation and
Toll样受体5(TLR5)重组蛋白precipitation were observed. (Referring from China Biological Products Standard,
which was calculated by the Arrhenius equation.) The loss of this protein is less
than 5% within the expiration date under appropriate storage condition.
[ SEQUENCES ]
The sequence of the target protein is listed below.
NTTER LLLSFNYIRT VTASSFPFLE QLQLLELGSQ YTPLTIDKEA FRNLPNLRIL DLGSSKIYFL
HPDAFQGLFH LFELRLYFCG LSDAVLKDGY FRNLKALTRL DLSKNQIRSL YLHPSFGKLN
SLKSIDFSSN QIFLVCEHEL EPLQGKTLSF FSLAA
[ REFERENCES ]
1. Chaudhary P.M., et al. (1998) Blood 91:4020-4027. 2. Nakajima T., et al. (2008) Immunogenetics 60:727-735. 3. Wlasiuk G., et al. (2009) Mol. Biol. Evol. 26:937-949. 4. Gregory S.G., et al. (2006) Nature 441:315-321.